560 related articles for article (PubMed ID: 30954437)
1. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.
Ozben T; Ozben S
Clin Biochem; 2019 Oct; 72():87-89. PubMed ID: 30954437
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
Halliday G; Robinson SR; Shepherd C; Kril J
Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
[TBL] [Abstract][Full Text] [Related]
3. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
[TBL] [Abstract][Full Text] [Related]
4. [Recent development of non-steroidal anti-inflammatory drugs on the neuro-inflammation of Alzheimer's disease].
Ma XW; Li JZ; Zhang TT; Du GH
Yao Xue Xue Bao; 2014 Sep; 49(9):1211-7. PubMed ID: 25518320
[TBL] [Abstract][Full Text] [Related]
5. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.
Hoozemans JJ; Rozemuller JM; van Haastert ES; Veerhuis R; Eikelenboom P
Curr Pharm Des; 2008; 14(14):1419-27. PubMed ID: 18537664
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Alzheimer's disease: protector or promoter?
Zilka N; Ferencik M; Hulin I
Bratisl Lek Listy; 2006; 107(9-10):374-83. PubMed ID: 17262990
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects of inflammation in Alzheimer's disease.
Rosenberg PB
Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549
[TBL] [Abstract][Full Text] [Related]
9. The role of COX-1 and COX-2 in Alzheimer's disease pathology and the therapeutic potentials of non-steroidal anti-inflammatory drugs.
Hoozemans JJ; O'Banion MK
Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):307-15. PubMed ID: 15975032
[TBL] [Abstract][Full Text] [Related]
10. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
11. Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective.
Apetz N; Munch G; Govindaraghavan S; Gyengesi E
CNS Neurol Disord Drug Targets; 2014; 13(7):1175-91. PubMed ID: 25230232
[TBL] [Abstract][Full Text] [Related]
12. Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.
Hoozemans JJ; Veerhuis R; Rozemuller JM; Eikelenboom P
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):57-67. PubMed ID: 21143138
[TBL] [Abstract][Full Text] [Related]
13. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
14. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
Bamberger ME; Landreth GE
Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
[TBL] [Abstract][Full Text] [Related]
15. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
16. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
17. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
18. Non-cholinergic pharmacotherapy approaches to Alzheimer's disease: the use of non-steroidal anti-inflammatory drugs.
Tsartsalis S; Panagopoulos PK; Mironidou-Tzouveleki M
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):133-9. PubMed ID: 20874697
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
Ferencik M; Novak M; Rovensky J; Rybar I
Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]